$SNBH
SENTIENT BRANDS HOLDINGS INC.

2023 Q3 Form 10-Q Financial Statement

#000173112223001565 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $142.00
YoY Change 13.6%
Cost Of Revenue $3.600K $4.214K
YoY Change -14.57% 18221.74%
Gross Profit $0.00 -$3.600K -$4.072K
YoY Change -11.59% -4092.16%
Gross Profit Margin -2867.61%
Selling, General & Admin $34.92K $44.22K $249.6K
YoY Change -17.37% -82.28% 4337.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $970.00 $970.00 $3.600K
YoY Change -158.08% -73.06% 188.0%
% of Gross Profit
Operating Expenses $34.92K $44.22K $290.4K
YoY Change -59.08% -84.78% 106.06%
Operating Profit -$34.92K -$47.82K -$294.5K
YoY Change -59.08% -83.76% 109.1%
Interest Expense $42.16K $41.90K $40.87K
YoY Change -2.11% 2.51% -5.54%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$77.07K -$89.71K -$294.5K
YoY Change -9.68% -69.54% 105.26%
Income Tax
% Of Pretax Income
Net Earnings -$77.07K -$89.71K -$294.5K
YoY Change -9.67% -69.54% 105.26%
Net Earnings / Revenue -207401.41%
Basic Earnings Per Share $0.00 $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$5.672K
COMMON SHARES
Basic Shares Outstanding 54.58M shares 54.58M shares 51.92M shares
Diluted Shares Outstanding 54.70M shares 54.58M shares 51.92M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.050K $50.00 $220.00
YoY Change -19.85% -77.27% -97.55%
Cash & Equivalents $1.049K $50.00 $223.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $213.5K $213.5K $244.5K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $214.5K $213.5K $244.7K
YoY Change -10.36% -12.74% -8.61%
LONG-TERM ASSETS
Property, Plant & Equipment $24.71K $25.68K $29.56K
YoY Change -13.57% -13.12% -13.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $24.71K $25.68K $29.56K
YoY Change -13.57% -13.12% -13.8%
TOTAL ASSETS
Total Short-Term Assets $214.5K $213.5K $244.7K
Total Long-Term Assets $24.71K $25.68K $29.56K
Total Assets $239.2K $239.2K $274.2K
YoY Change -10.7% -12.78% -9.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $553.7K $514.6K $390.9K
YoY Change 16.92% 31.66% 82.46%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.392M $1.392M $1.330M
YoY Change 7.08% 4.67% 50.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.946M $1.907M $1.721M
YoY Change 9.7% 10.8% 56.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.946M $1.907M $1.721M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.946M $1.907M $1.721M
YoY Change 9.7% 10.8% 56.56%
SHAREHOLDERS EQUITY
Retained Earnings -$3.298M -$3.221M -$2.833M
YoY Change 13.01% 13.69%
Common Stock $55.34K $54.58K $51.92K
YoY Change 5.57% 5.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.707M -$1.668M -$1.447M
YoY Change
Total Liabilities & Shareholders Equity $239.2K $239.2K $274.2K
YoY Change -10.7% -12.78% -9.2%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$77.07K -$89.71K -$294.5K
YoY Change -9.67% -69.54% 105.26%
Depreciation, Depletion And Amortization $970.00 $970.00 $3.600K
YoY Change -158.08% -73.06% 188.0%
Cash From Operating Activities -$37.00K -$13.53K -$83.26K
YoY Change 163.16% -83.75% -71.97%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 38.00K 13.40K 73.05K
YoY Change 150.99% -81.66% -75.13%
NET CHANGE
Cash From Operating Activities -37.00K -13.53K -83.26K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 38.00K 13.40K 73.05K
Net Change In Cash 1.000K -130.0 -10.21K
YoY Change -7.41% -98.73% 204.78%
FREE CASH FLOW
Cash From Operating Activities -$37.00K -$13.53K -$83.26K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$37.00K -$13.53K -$83.26K
YoY Change 163.16% -83.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001358633
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34861
dei Entity Registrant Name
EntityRegistrantName
SENTIENT BRANDS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3765910
dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
21st Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
202-2897
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54580518 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
213477 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
238016 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
213527 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
239064 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25681 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27620 usd
CY2023Q2 us-gaap Assets
Assets
239208 usd
CY2022Q4 us-gaap Assets
Assets
266684 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
514602 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
540217 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
533191 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
482896 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
859047 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
886547 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1906840 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1909660 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1906840 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1909660 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54580518 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54580518 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52420387 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52420387 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
54581 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
52421 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1497989 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1359249 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3221202 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3055646 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1667632 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239208 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266684 usd
CY2022Q2 us-gaap Revenues
Revenues
142 usd
us-gaap Revenues
Revenues
150 usd
us-gaap Revenues
Revenues
553 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3600 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4214 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7830 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4323 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-3600 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-4072 usd
us-gaap Gross Profit
GrossProfit
-7680 usd
us-gaap Gross Profit
GrossProfit
-3770 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
453 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
6865 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
988 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
38613 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21763 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12303 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26487 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19887 usd
CY2023Q2 us-gaap Legal Fees
LegalFees
22000 usd
CY2022Q2 us-gaap Legal Fees
LegalFees
215399 usd
us-gaap Legal Fees
LegalFees
47900 usd
us-gaap Legal Fees
LegalFees
311039 usd
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
15000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
69000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
44216 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
249567 usd
us-gaap Operating Expenses
OperatingExpenses
75375 usd
us-gaap Operating Expenses
OperatingExpenses
438539 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47816 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-253639 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-83055 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-442309 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
41895 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
40871 usd
us-gaap Interest Expense
InterestExpense
82501 usd
us-gaap Interest Expense
InterestExpense
70032 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-89711 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-294510 usd
us-gaap Net Income Loss
NetIncomeLoss
-165556 usd
us-gaap Net Income Loss
NetIncomeLoss
-512341 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.006
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.010
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.010
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54580518 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54580518 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51920387 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51920387 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54520846 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54520846 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51920387 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51920387 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023Q1 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
127000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13900 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-75845 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1577921 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-89711 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1667632 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-934421 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-217831 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1152252 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-294510 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1446762 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
165556 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
512342 usd
us-gaap Depreciation
Depreciation
1939 usd
us-gaap Depreciation
Depreciation
4855 usd
snbh Common Stock Issued In Payments Of Past Services
CommonStockIssuedInPaymentsOfPastServices
127000 usd
snbh Common Stock Issued For Services
CommonStockIssuedForServices
-13900 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24539 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14314 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25615 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
219414 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23793 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-273759 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22795 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
177784 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22795 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177784 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-998 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95975 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1048 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96198 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223 usd
us-gaap Interest Paid Net
InterestPaidNet
21052 usd
CY2020Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
7 for 1
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3221202 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
165556 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23793 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zrq6ifBNTe5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_862_zEt31TKtmcUi">Uses of estimates in the preparation of financial statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zk9HwV8SXHBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_86F_zCbv8yqEkw8k">Reclassifications</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to the 2022 presentation to make them consistent with 2023<i>.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Inventory Net
InventoryNet
213477 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
238016 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
7 for 1
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares

Files In Submission

Name View Source Status
0001731122-23-001565-index-headers.html Edgar Link pending
0001731122-23-001565-index.html Edgar Link pending
0001731122-23-001565.txt Edgar Link pending
0001731122-23-001565-xbrl.zip Edgar Link pending
e4961_10q.htm Edgar Link pending
e4961_ex31-1.htm Edgar Link pending
e4961_ex31-2.htm Edgar Link pending
e4961_ex32.htm Edgar Link pending
e4961_10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbh-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
snbh-20230630_cal.xml Edgar Link unprocessable
snbh-20230630_def.xml Edgar Link unprocessable
snbh-20230630_pre.xml Edgar Link unprocessable
snbh-20230630_lab.xml Edgar Link unprocessable